Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Fostemsavir and Maraviroc in Healthy Subjects
NCT02480894Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fostemsavir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Plasma Concentration-Time Curve in a Single Dosing Interval. Started Jul 2015; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02480894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480894.